Clin2
NCT07730853Possibly a fitNot yet recruiting

Navy beans for fatty liver disease

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)Liver FibrosisMetabolic Dysfunction-Associated Steatohepatitis (MASH)

Part of Digestive system clinical trials.

This study tests whether adding navy beans to your regular diet can reduce liver fat and improve liver health in people with a type of fatty liver disease called MASLD. You'll eat beans daily for several months and attend regular checkups, including MRI scans and blood tests.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
40 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 to 75 years old
  • You have a confirmed diagnosis of fatty liver disease (MASLD) with moderate liver scarring
  • Your body mass index (BMI) is between 25 and 45
  • You are willing to eat navy beans every day and fill out food diaries
  • You can have an MRI (no metal implants, no severe claustrophobia) and provide blood, stool, and saliva samples
  • You have not had major changes in weight, medications, or supplements in the last few months

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07877272Recruiting
Better liver testing for high-risk fatty liver disease

This study tests a more detailed way to examine the liver in people with fatty liver disease who also have other health risks. The doctors want to see if this extra testing helps decide whether you need treatment.

Münster
NCT07313007Recruiting
Gut bacteria chemicals in fatty liver disease

This study looks at whether the natural chemicals made by your gut bacteria from the food you eat could affect liver fat and health. If you have MASLD (a fatty liver condition), researchers want to measure these gut-produced substances to better understand the disease.

Pierre-Bénite
NCT06845345Enrolling by invitation· Phase 4
Can a special diet or pills help liver health?

This study compares two treatments for liver scarring in people with overweight or related health issues. One group follows a special diet with restricted eating times, while the other takes a combination of two medications (naltrexone and bupropion). It aims to see which approach better improves liver fibrosis.

Rotterdam
NCT06703450Enrolling by invitation
Liver fibrosis study with MRI for MASLD patients

This study is testing whether an MRI can help doctors see liver scarring (fibrosis) in people with MASLD, a type of fatty liver disease. It is for patients who already need a liver biopsy as part of their care, to compare the MRI results with the biopsy.

New York, New York
NCT06836609Recruiting· Phase 1/Phase 2
Study of a new drug for fatty liver disease (MASLD/MASH)

This study tests a new drug called ALN-CIDEB for people with fatty liver disease (MASLD or MASH). The goal is to see if it can reduce liver fat and improve liver health. You may qualify if you have a higher BMI and evidence of liver fat on imaging tests.

Chandler, Arizona
NCT07503431Not yet recruiting
Plant-based diet for fatty liver disease

This trial tests whether eating a plant-based diet can improve liver health and reduce exposure to harmful chemicals in people with fatty liver disease. If you qualify, you may be asked to follow a plant-based diet and have your liver health monitored over time.

Madrid

Hear when a new Liver Fibrosis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.